PAPER Petit P, Gondard E, Gandon G, Moreaud O, Sauvée M, Bonneterre V
SEARCH RESULTS
331076 RESULTS
PAPER Park JE, Chaudhary CL, Bhattarai D, Kim KB
Brain-Permeable Immunoproteasome-Targeting Macrocyclic Peptide Epoxyketones for Alzheimer's Disease.
J Med Chem. 2024 Apr 18; PubMed: 38636481PAPER Limberger C, Zimmer ER
Blood GFAP reflects astrocyte reactivity to Alzheimer's pathology in post-mortem brain tissue.
Brain. 2024 Apr 18; PubMed: 38634672PAPER Andrade SM, de Oliveira Marques CC, de Lucena LC, Vieira da Costa K, de Souza IC, da Silva Machado CB, Queiroz ME, Costa LP, Silva ST
Effect of transcranial direct current stimulation and transcranial magnetic stimulation on the cognitive function of individuals with Alzheimer's disease: a systematic review with meta-analysis and meta-regression.
Neurol Res. 2024 Apr 18;:1-13. PubMed: 38634361PAPER Huang Z, He G, Sun S, Huang Y
Causal relationship of genetically predicted particulate matter 2.5 level with Alzheimer's disease and the mediating effect of dehydroepiandrosterone sulphate.
Ann Hum Biol. 2024 Feb;51(1):2337731. Epub 2024 Apr 18 PubMed: 38634600PAPER Schlein E, Andersson KG, Dallas T, Syvänen S, Sehlin D
Reducing neonatal Fc receptor binding enhances clearance and brain-to-blood ratio of TfR-delivered bispecific amyloid-β antibody.
MAbs. 2024;16(1):2339337. Epub 2024 Apr 18 PubMed: 38634473PAPER Singh SP, Gupta S, Rajapakse JC
Sparse Deep Neural Network for Encoding and Decoding the Structural Connectome.
IEEE J Transl Eng Health Med. 2024;12:371-381. Epub 2024 Feb 19 PubMed: 38633564PAPER Khalil B, Da Cruz S
14-3-3θ, a novel player in TDP-43 pathophysiology: Implications for ALS/FTD.
Neuron. 2024 Apr 17;112(8):1197-1199. PubMed: 38636451PAPER Lacey C, Paterson T, Gawryluk JR, Alzheimer’s Disease Neuroimaging Initiative
Impact of APOE-ε alleles on brain structure and cognitive function in healthy older adults: A VBM and DTI replication study.
PLoS One. 2024;19(4):e0292576. Epub 2024 Apr 18 PubMed: 38635499Jess Smith
Australia
PAPER Singh SL, Bhat R
Cyclic-NDGA Effectively Inhibits Human γ-Synuclein Fibrillation, Forms Nontoxic Off-Pathway Species, and Disintegrates Preformed Mature Fibrils.
ACS Chem Neurosci. 2024 Apr 18; PubMed: 38637513PAPER Heesink G, van den Oetelaar MC, Semerdzhiev SA, Ottmann C, Brunsveld L, Blum C, Claessens MM
14-3-3τ as a Modulator of Early α-Synuclein Multimerization and Amyloid Formation.
ACS Chem Neurosci. 2024 Apr 18; PubMed: 38635928PAPER Matveyenka M, Zhaliazka K, Kurouski D
Macrophages and Natural Killers Degrade α-Synuclein Aggregates.
Mol Pharm. 2024 Apr 18; PubMed: 38635186PAPER Wang J, Huang Q, He K, Li J, Guo T, Yang Y, Lin Z, Li S, Vanderlinden G, Huang Y, Van Laere K, Guan Y, Guo Q, Ni R, Li B, Xie F
Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment.
Alzheimers Dement. 2024 Apr 18; PubMed: 38634334PAPER Mei N, Liang J, McRae DM, Leonenko Z
Localized surface plasmon resonance and atomic force microscopy study of model lipid membranes and their interactions with amyloid and melatonin.
Nanotechnology. 2024 Apr 18; PubMed: 38636478Current Filters
No filters selected